Embolization of prostatic arteries to stop bleeding in prostate cancer

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Prostatic bleeding is life-threatening, and its most common cause is locally advanced prostate cancer. In several patients, hemostatic therapy is ineffective. Surgery is not feasible in most patients owing to the high surgical risk. In such cases, prostatic artery embolization may be the method of choice to stop the bleeding. This procedure is minimally invasive; thus, it can be performed in patients with contraindications to more extensive operations. Despite limited experience with embolization of prostatic arteries, according to the literature, it is effective in 90% of treated patients. This article provides a review of the literature and clinical observations of the successful use of prostatic artery embolization to stop bleeding in patients with locally advanced prostate cancer.

About the authors

Sergei B. Petrov

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: petrov-uro@yandex.ru
ORCID iD: 0000-0003-3460-3427
Scopus Author ID: 7201794299

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

Yulia A. Ponomareva

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: uaponomareva@mail.ru
ORCID iD: 0000-0003-3492-4220

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

Sofya Yu. Glazneva

Academician I.P. Pavlov First Saint Petersburg State Medical University

Author for correspondence.
Email: cezar81@mail.ru

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

Dmitrii V. Ovcharenko

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: dovcharenko@icloud.com
SPIN-code: 3574-6524

MD, Cand. Sci. (Medicine)

 

Russian Federation, Saint Petersburg

Kirill A. Smirnov

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: kirsmirnov1990@gmail.com

MD

Russian Federation, Saint Petersburg

Tatiana V. Ulitko

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: ulitko-ta@yandex.ru
ORCID iD: 0000-0002-3521-8048
SPIN-code: 1194-2697

MD

Russian Federation, Saint Petersburg

Adel S. Al-Shukri

Academician I.P. Pavlov First Saint Petersburg State Medical University

Email: ad330@mail.ru
ORCID iD: 0000-0001-6543-8589
SPIN-code: 5024-2184
Scopus Author ID: 28367540300

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

References

  1. Somov AN, Suslin SA. Prostate cancer. Epidemiology, risk factors and early detection. Russian journal of preventive medicine and public health. 2020;23(3):149–155. EDN: GZQTTB doi: 10.17116/profmed202023031149
  2. Karpov YeI. Prophylaxis of prostate cancer: current status of the problem. Effective pharmacotherapy. Urology and nephrology. 2015;(3):32–37. EDN: OBBMNL
  3. Khvastunov RA. Prostate cancer. Journal of Volgograd State Medical University. 2008;(3):3–8. EDN: JSKERB
  4. Chen J-W, Shin JH, Tsao T-F, et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer. J Vasc Interv Radiol. 2017;28(2):295–301. doi: 10.1016/j.jvir.2016.10.010
  5. Pereira K, Halpern JA, McClure TD, et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU Int. 2016;118(3):359–365. doi: 10.1111/bju.13524
  6. Gorelov DS, Gadzhiev NK, Ovcharenko DV, et ap. Prostatic artery embolisation in treatment of benign prostatic hyperplasia. Urology and Andrology. 2018;6(3):38–42. EDN: YVXAGL doi: 10.20953/2307-6631-2018-3-38-42
  7. Shim SR, Kanhai KJ, Ko YM, Kim JH. Efficacy and safety of prostatic arterial embolization: systematic review with meta-analysis and meta-regression. J Urol. 2017;197(2):465–479. doi: 10.1016/j.juro.2016.08.100
  8. Korkmaz M, Şanal B, Aras B, et al. The short- and long-term effectiveness of transcatheter arterial embolization in patients with intractable hematuria. Diagn Interv Imaging. 2016;97(2):197–201. doi: 10.1016/j.diii.2015.06.020
  9. Loffroy R, Pottecher P, Cherblanc V, et al. Current role of transcatheter arterial embolization for bladder and prostate hemorrhage. Diagn Interv Imaging. 2014;95(11):1027–1034. doi: 10.1016/j.diii.2014.03.008
  10. Carmignani G, Belgrano E, Puppo P, et al. Transcatheter embilization of the hypogastric arteries in cases of bladder hemorrhage from advanced pelvic cancers: follow up in 9 cases. J Urol. 1980;124(2):196–200. doi: 10.1016/s0022-5347(17)55371-9
  11. Appleton DS, Sibley GNA, Doyle PT. Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol. 1988;61(1):45–47. doi: 10.1111/j.1464-410x.1988.tb09160.x
  12. Pisco JM, Martins JM, Correia MG. Internal iliac artery: embolization to control hemorrhage from pelvic neoplasms. Radiology. 1989;172(2):337–339. doi: 10.1148/radiology.172.2.2748811
  13. Sieber PR. Bladder necrosis secondary to pelvic artery embolization: case report and literature review. J Urol. 1994;151(2):422. doi: 10.1016/s0022-5347(17)34969-8
  14. Rastinehad AR, Caplin DM, Ost MC, et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology. 2008;71(2):181–184. doi: 10.1016/j.urology.2007.09.012
  15. Delgal A, Cercueil J-P, Koutlidis N, et al. Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage. J Urol. 2010;183(5):1947–1953. doi: 10.1016/j.juro.2010.01.003
  16. Prasad V, Sacks BA, Kraus S, Clouse ME. Embolotherapy for lower urinary tract hemorrhage. J Vasc Interv Radiol. 2009;20(7): 965–970. doi: 10.1016/j.jvir.2009.04.048
  17. Cizman Z, Isaacson A, Burke C. Short- to midterm safety and efficacy of prostatic artery embolization: A systematic review. J Vasc Interv Radiol. 2016;27(10):1487–1493.e1. doi: 10.1016/j.jvir.2016.04.015

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ №ФС77-65570 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies